Posted in | News | Fuel Cell

Viaspace Patent Soft Ionization Membrane for Next Generation Mass Spectrometry Applications

VIASPACE Inc., a company that transforms proven space and defense technologies from NASA and the Department of Defense into hardware and software solutions, announced today that its Ionfinity subsidiary has been granted a patent for a soft ionization membrane. Ionfinity, a subsidiary in which VIASPACE holds a 46.3% membership interest, is working to develop the next-generation mass spectrometry (MS) technology, which could not only revolutionize the traditional applications of MS for industrial process control and environmental monitoring, but could also ring in a new era of detection systems for homeland security. The technology combines two inventions made at NASA Jet Propulsion Laboratory, which should enable the system to provide a 10x increase in sensitivity, a 10x increase in mass range and the ability to miniaturize the product to make it portable and low cost.

The Ionfinity system is designed to allow high sensitivity and specificity in a portable system – a carry-on suitcase in the near-term and a shoe box or smaller size in the future. With its projected ruggedness, low power consumption and cost, the system could be deployed in many applications, where monitoring of air, water or other substances is required. This patent application concerns the soft ionization membrane, designed to work with the mass spectrometer or in other applications such as propulsion systems and fuel cells.

Dr. Carl Kukkonen, CEO of both VIASPACE and Ionfinity, reports, “With this new soft ionization membrane patent, we are continuing to add to our substantial intellectual property portfolio. Ionfinity is presently focusing on a new system for detection in the homeland security market. This patent is a key element of our strategy to provide a 10x increase in sensitivity in a miniaturized, highly portable, low cost monitoring unit”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.